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to uniquely relate to plan quality. The quality of the plan
was strongly linked to satisfaction. CONCLUSIONS:
Overall, consumers rated the quality of their Rx plan as
high, were generally satisﬁed with their plans and ranked
the importance as high. The results indicate that plan
quality was dependent on satisfaction with out-of-pocket
payments. We also found that plan importance was pre-
dominately driven by consumer’s personal awareness of
the need for prescription medications. As consumer infor-
mation on Rx plans becomes more available, it is imper-
ative that information be presented in such a way as to
assist consumers in comparing and selecting appropriate
plans.
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OBJECTIVE: To investigate the market share of generics,
their production and promotion process by the Greek
pharmaceutical industry. METHODS: Analyses are based
on questionnaire mailed to companies members of the
Greek Federation of Pharmaceutical Companies, in 2002
with a response rate of 52%. Questionnaire was divided
in three sections, ﬁrst requested information on the com-
panies’ involvement in the production of generics, second
on companies’ opinion regarding generics characteristics
and government interventions, third on policies affected
generics demand. Data was analyzed in two stages, 
ﬁrst concerning detailed description of outcomes and
second percentage comparisons through binomial tests.
RESULTS: A total of 46.4% of the companies are
involved in the production and distribution of generics
while 53.6% are not, their difference is not statistically
signiﬁcant (equality of percentages test p = 0.59). The
mean period of companies involvement is 12 years while
80.8% of the respondents expressed positively for their
companies involvement in generics. A total of 30.8% of
the companies consider that the most important charac-
teristic of generics is that they are safe and cheap substi-
tutes of the brand drugs. Of the companies, 88.5%
consider government does not promote the prescription
of generics, whereas 11.5% had different opinion, bino-
mial test for the equality of percentages resulted in p <
0.001, meaning that the difference is statistically signiﬁ-
cant. The majority of companies (70.4%) consider that
cost-effectiveness analyses should be the criteria for inclu-
sion in the prescribed drug list vs. 18.5% the cost of treat-
ment, 3.7% for reference pricing and 3.7% for the daily
dose cost of treatment. Finally, majority of companies
consider the positive list as the most important factor for
the promotion of generics from health professionals.
CONCLUSION: Generics share in Greece is lower com-
pared to the EU countries. High share of imported brand
drugs, irrational pricing and parallel exports are main
factors contributing to continuing increase in drug expen-
diture and decrease in the drug production of Greek
industry.
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OBJECTIVES: To demonstrate the impact of staff phar-
macists of interventions at a large (2389 beds), tertiary
care teaching hospital in Southern Taiwan. METHODS:
Based on the self-reported documentation made by phar-
macists during the conduct of routine dispensing activi-
ties in ambulatory and inpatient setting. Those intervened
suggestions were accepted by prescribing physicians. A
peer-review team decided the potential clinical signiﬁ-
cance of the self-reported documentation, and assessed
their cost savings results. Data collection period was from
January 1 to December 31, 2001. RESULTS: A total of
4424 interventions (94.8% of reported documentations)
by 25 pharmacists were analyzed. Of which, 59.4% of
these interventions were found to affect inappropriate
prescribing, 35.4% of these interventions were associated
with inappropriate drug utilization and the remaining
5.2% of interventions were drug interactions and mis-
cellaneousness. Six percent of reported documents were
evaluated in terms of direct cost savings (the difference 
in actual acquisition costs between prescriptions). Cost
savings were over $7400 and average $27 per interven-
tion for those sampled data. The most cost-saving 
interventions were related to incorrect quantity with the
indication, no indication, and improper concomitants/
duplication. CONCLUSIONS: The self-report documen-
tation tool in this constitute conﬁrms the potential to min-
imize the risks, cost saving and to improve hospital
prescribing associated with drug therapy.
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OBJECTIVES: Expenditure on medicines continues to
increase signiﬁcantly in Ireland. Total payments to phar-
macies by the state for the year 2001 was €674.8 million,
a 27% increase as compared with the year 2000. Pre-
scribing less expensive generic preparations is one method
of reducing costs while maintaining therapeutic efﬁcacy.
While generic prescribing is encouraged, generic substi-
tution by pharmacists is not permitted. In this study the
